Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Febrile Seizures Companies

Febrile seizures are seizures that occur in children due to a sudden spike in body temperature, often associated with a fever. While febrile seizures are generally considered harmless, companies involved in healthcare and pharmaceuticals may develop medications, diagnostic tools, or supportive therapies related to the condition.

Febrile Seizures Market

Latest Febrile Seizures Companies Updates

Eisai Co., Ltd.: Received FDA approval for Fycompa® (perampanel) in October 2023 as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome, potentially offering a new option for children with febrile seizures who experience subsequent epilepsy.

Medtronic plc: Collaborated with the American Academy of Pediatrics in December 2023 to launch the Febrile Seizure Education Initiative, aiming to provide resources and education to parents and healthcare professionals about managing febrile seizures.

UCB Inc.: Partnered with the University of California, San Diego in November 2023 to research the potential of genetic factors in predicting febrile seizure recurrence, paving the way for personalized prevention strategies.

Neuropace, Inc.: Announced the expansion of their RNS® System clinical trial for pediatric epilepsy in August 2023, potentially opening doors for more targeted treatment options for febrile-onset epilepsy.

BrainSentinel, Inc.: Developed the FebriTemp® Smart Thermometer with early seizure detection alerts, currently undergoing FDA review and aiming to provide real-time monitoring for parents and caregivers.

List of Febrile Seizures Key companies in the market:

Sanofi

Cardinal Health

Merck

Pfizer

Johnson & Johnson

Abbott Laboratories

GlaxoSmithKline plc

Cephalon Inc.

Shire

Febrile Seizures Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.